Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Recruiting
N/A
Interventional Study
Gastrointestinal Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 22 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 66 (estimated)
- Sponsor
- Baylor College of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety efficacy, and clinical outcomes of colonic endoscopic submucosal dissection (ESD) utilizing a novel rigidizing overtube called Pathfinder® Endoscope Overtube (Neptune Medical, Burlingame California, USA) device in comparison to conventional ESD.
…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient is ≥ 22 years old.
* Patients can provide written informed consent.
* Patient is referred for ESD procedure of colonic neoplastic lesions and with one of the following criteria:
A - Lesions with prior resection or with scar at any size proximal to the sigmoid colon.
…
Contacts